Compare DUKR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUKR | GNTA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Israel | Italy |
| Employees | N/A | 13 |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 19.9M |
| IPO Year | N/A | N/A |
| Metric | DUKR | GNTA |
|---|---|---|
| Price | $5.50 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.9K | ★ 166.1K |
| Earning Date | N/A | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.75 | $0.55 |
| 52 Week High | $7.41 | $10.00 |
| Indicator | DUKR | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.83 | 44.74 |
| Support Level | $5.02 | $1.31 |
| Resistance Level | $5.80 | $1.70 |
| Average True Range (ATR) | 0.76 | 0.14 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 28.57 | 0.00 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.